Cover ImageSALE
Market Research Report

PTCA Balloon Catheter Market in China 2015-2019

Published by TechNavio (Infiniti Research Ltd.) Product code 336540
Published Content info 106 Pages
Delivery time: 1-2 business days
Price
Back to Top
PTCA Balloon Catheter Market in China 2015-2019
Published: July 29, 2015 Content info: 106 Pages
Description

About PTCA balloon catheter

PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries, permitting uninterrupted blood flow to the heart muscle. The procedure involves the placement of a PTCA balloon catheter to compress and clear the blockage caused by plaques and to widen the clogged coronary artery. A PTCA balloon catheter is a soft device equipped with a small inflatable balloon at its tip, which is inserted into an artery during the catheterization procedure. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheter was the first of its kind used in the field of interventional cardiology. It is also used to position stents during angioplasty.

Technavio's analysts forecast the PTCA balloon catheter market in China to grow at a CAGR of 14.75% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the PTCA balloon catheter market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of PTCA balloon catheters.

Technavio's report, PTCA Balloon Catheter Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • MicroPort Scientific
  • Terumo

Other Prominent Vendors

  • Aachen Resonance
  • Acrostak
  • AngioScore
  • Alvimedica
  • Asahi Intecc
  • Arthesys
  • Atrium Medical
  • B. Braun Melsungen
  • Biosensors International
  • BIOTRONIK
  • Cordis
  • Cook Medical
  • C.R. Bard
  • Goodman
  • Lepu Medical
  • Natec Medical
  • Smiths Medical
  • Tokai Medical Products
  • Volcano

Market driver

  • Growing geriatric population
  • For a full, detailed list, view our report

Market challenge

  • Alternative therapies
  • For a full, detailed list, view our report

Market trend

  • High demand for minimally invasive procedures
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Table of Contents
Product Code: IRTNTR6811

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. PTCA: An Overview

  • 06.1. About PTCA
    • 06.1.1. Background
    • 06.1.2. Definition
    • 06.1.3. Steps Involved in PTCA
    • 06.1.4. Advantages of PTCA
    • 06.1.5. Complications and Risks Involved in PTCA
    • 06.1.6. PTCA Balloon Catheters Affected Individuals
  • 06.2. PTCA Balloon Catheter Materials
    • 06.2.1. Comparison of Catheter Materials
  • 06.3. Complications of Catheterization
    • 06.3.1. Background
    • 06.3.2. Causes of Complications

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Product Type

  • 08.1. Normal Balloon Catheter
  • 08.2. Drug-Eluting Balloon Catheter
  • 08.3. Cutting Balloon Catheter
  • 08.4. Scoring Balloon Catheter

09. Healthcare Reform in China

  • 09.1. Healthcare Reforms
    • 09.1.1. Insurance Coverage for Healthcare Access
    • 09.1.2. Improvement in Healthcare Infrastructure

10. Opportunities for Global and Local Vendors

  • 10.1. Local Vendors
    • 10.1.1. Challenges for Local Vendors
  • 10.2. Global Vendors
    • 10.2.1. Challenges for Global Vendors

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and Their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and Their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2014
    • 18.2.1. Abbott Laboratories
    • 18.2.2. Boston Scientific
    • 18.2.3. Medtronic
    • 18.2.4. MicroPort Scientific
    • 18.2.5. Terumo
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Boston Scientific
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Key Products
    • 19.2.4. Key Products in Cardiovascular Segment
    • 19.2.5. Key Products in MedSurg Segment
    • 19.2.6. Key Products in Rhythm Management Segment
    • 19.2.7. Business Segmentation by Revenue 2013
    • 19.2.8. Business Segmentation by Revenue 2012 and 2013
    • 19.2.9. Geographical Segmentation by Revenue 2013
    • 19.2.10. Business Strategy
    • 19.2.11. Recent Developments
    • 19.2.12. SWOT Analysis
  • 19.3. Medtronic
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Key Products
    • 19.3.4. Business Segmentation by Revenue 2014
    • 19.3.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 19.3.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 19.3.7. Diabetes Group Segmentation by Revenue 2014
    • 19.3.8. Business Segmentation by Revenue 2013 and 2014
    • 19.3.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 19.3.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 19.3.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 19.3.12. Geographical Segmentation by Revenue 2014
    • 19.3.13. Business Strategy
    • 19.3.14. Key Developments
    • 19.3.15. SWOT Analysis
  • 19.4. MicroPort Scientific
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation by Revenue 2013
    • 19.4.4. Business Segmentation by Revenue 2012 and 2013
    • 19.4.5. Geographical Segmentation by Revenue 2013
    • 19.4.6. Business Strategy
    • 19.4.7. Recent Developments
    • 19.4.8. SWOT Analysis
  • 19.5. Terumo
    • 19.5.1. Key Facts
    • 19.5.2. Business Overview
    • 19.5.3. Business Segmentation
    • 19.5.4. Revenue Segmentation by Business
    • 19.5.5. Business Segment Revenue Comparison - FY2011 and FY2012
    • 19.5.6. Revenue Segmentation by Geography
    • 19.5.7. Business Strategy
    • 19.5.8. Key Developments
    • 19.5.9. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Various Steps of PTCA
  • Exhibit 3: PTCA Balloon Catheter Materials
  • Exhibit 4: Common HAIs in Acute Care Settings
  • Exhibit 5: Major PTCA Balloon Catheter Complications
  • Exhibit 2: PTCA Balloon Catheter Market in China 2014-2019 ($ millions)
  • Exhibit 6: Segmentation of PTCA Balloon Catheter Market in China by Product Type
  • Exhibit 7: Segmentation of PTCA Balloon Catheter Market in China by Product Type 2014
  • Exhibit 8: Disease Mortality in China 2012
  • Exhibit 9: Healthcare Reforms in China
  • Exhibit 10: Number of Medical Institutes in China until 2012
  • Exhibit 11: Various Establishments of Top Global Medical Device Companies in China
  • Exhibit 12: Elderly Population in China 1950-2050
  • Exhibit 13: Healthcare Expenditure in China 2005-2014
  • Exhibit 14: Abbott Laboratories: Key Takeaways
  • Exhibit 15: Boston Scientific: Key Takeaways
  • Exhibit 16: Medtronic: Key Takeaways
  • Exhibit 17: MicroPort Scientific: Key Takeaways
  • Exhibit 18: Terumo: Key Takeaways
  • Exhibit 19: Abbott Laboratories: Business Segmentation
  • Exhibit 20: Abbott Laboratories: Revenue by Business Segmentation 2012
  • Exhibit 21: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
  • Exhibit 22: Abbott Laboratories: Revenue by Geographical Segmentation 2012
  • Exhibit 23: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 24: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 25: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 27: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 28: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 29: Medtronic: Key Products
  • Exhibit 30: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 31: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 32: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 33: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 34: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 35: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 36: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 37: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 38: Medtronic: Geographical Segmentation by Revenue 2014
  • Exhibit 39: MicroPort Scientific: Business Segmentation by Revenue 2013
  • Exhibit 40: MicroPort Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 41: MicroPort Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 42: Business Segmentation of Terumo
  • Exhibit 43: Revenue Segmentation of Terumo
  • Exhibit 44: Revenue Comparison of Business Segments ($ billions)
  • Exhibit 45: Revenue Segmentation by Geography FY2012
Back to Top